European Companies Search Engine

Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

Glaxosmithkline Services Unlimited, London

Watch
Glaxosmithkline Services Unlimited

If you put a company on your watch list, we'll notify you on your email address when there are new publications regarding this company.

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Premium Service
Unlock Dossier
What is a Dossier?
A dossier provides comprehensive company details as a PDF, together with all underlying original publications and original data in one place.
The download feature is exclusively available for our paid plan. Upgrade your account to access:
Quick Dossier
Entire company details as a PDF
Power Dossier
Entire company details along with all original publications / original data bundled in a ZIP file
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more
Learn more
View plans

Name

Glaxosmithkline Services Unlimited
Glaxo Wellcome plc
Glaxo plc
Glaxo Holdings plc

Identification

Chp
Companies House 01047315
Lei
549300QH465T0AATXR10

Address

79 New Oxford Street, London WC1A 1DG, United Kingdom
Middlesex, United Kingdom

Corporate purpose

70.10
Activities of head offices

Financial performance

Earnings

For this company, Earnings numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

Revenue

For this company, Revenue numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

Employees

For this company, Employees numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

History

Network

Loading network

Legal Structure

Current legal representatives Premium
Premium
2Director
1Secretary
2Director
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more View plans
Learn more View plans
Ownership relations Premium + Ownership & Flags add-on
Premium + Ownership & Flags add-on
Shareholders and Investors
2 known active shareholders
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more View plans
Learn more View plans

Financials

Key Performance Indicators Financial · Mktg & Tech Premium
Premium
Base/share capital
Total assets
Earnings
Earnings CAGR
Revenue
Revenue CAGR
Return on sales
Equity
Equity ratio
Return on equity
Employee number
Revenue per employee
Taxes
Tax ratio
Cash on hand
Liabilities
Average salaries per employee
Number of public fundings
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more View plans
Learn more View plans

Publications

10 Aug 2026 also 10/10/2016, 04/10/2015, 22/10/2014, 07/08/2013, 29/08/2012, 28/07/2011, 22/06/2010, 28/05/2009, 30/10/2008, 25/10/2007, 21/09/2006, 07/04/2005
Full accounts made up to 2025-12-31
20 Apr 2026 also 04/08/2025, 15/08/2024, 15/08/2023, 10/08/2021, 25/08/2020, 29/08/2019, 22/08/2018, 15/08/2017
Confirmation statement made with no updates
18 Aug 2025
Annual report for the year ending 31/12/2024
1 Jan 2025 via Decision LAB Ltd.
UK funding: Optimising Energy Efficiency for Sustainable Medicines Manufacturing
23 Sept 2024
Secretary's details changed for Mrs Victoria Anne Whyte · Director's details changed for Mrs Julie Belita Brown
17 Sept 2024
Director's details changed for Mr Adam Walker
11 Sept 2024
Address
4 Sept 2024
Annual report for the year ending 31/12/2023
18 Jul 2024
Address
17 Aug 2023
Annual report for the year ending 31/12/2022
16 Aug 2023
Director's details changed for Glaxo Group Limited
11 May 2023
Director: Julie Belita Brown
10 Oct 2022
Annual report for the year ending 31/12/2021
18 Aug 2022 also 22/08/2016
Confirmation statement made with updates
15 Jul 2022
Companies House - Filing
22 Oct 2021
Annual report for the year ending 31/12/2020
13 Oct 2020
Annual report for the year ending 31/12/2019
25 Sept 2019
Annual report for the year ending 31/12/2018
2 Jul 2019
Director: Adam Walker
7 May 2019
No longer Director: Simon Paul Dingemans
30 Sept 2018
Annual report for the year ending 31/12/2017
7 Oct 2017
Annual report for the year ending 31/12/2016
27 Aug 2015
Capital: £713M
18 Aug 2014
Capital: £713M
1 Jul 2014 via Astrazeneca UK Ltd.
UK funding (£70,959): Accelerating paediatric formulation development through smart design and predictive science
1 Jun 2014 via Siemens Process Systems Engineering Ltd.
UK funding (£30,204): Digital Design of Drug Products
28 Aug 2013
Capital: £713M
1 Apr 2013 via Unchained Labs Royston Ltd.
UK funding (£10,000.00): Development of an Innovative Modular System for Continuous Chemical Processing
14 Sept 2012 also 16/09/2010
Annual return made up to 2012-08-15 with full list of shareholders
6 Oct 2011
Director's details changed for Edinburgh Pharmaceutical Industries Limited · Director's details changed for Glaxo Group …
17 Aug 2011
Annual return made up to 2011-08-15 with full list of shareholders · Director's details changed for Glaxo Group Limited
8 Apr 2011
Director: Simon Paul Dingemans
6 Apr 2011
No longer Director (1)
3 Mar 2011
No longer Secretary (1)
3 Mar 2010
Deed of assignment with smithkline corporation 23/10/2009
18 Sept 2009
Director (1)
18 Aug 2009 also 11/09/2008, 12/09/2006
Return made up to 15/08/09; full list of members
26 Sept 2007
Return made up to 15/08/07; no change of members
28 Apr 2006 also 14/02/2006
Secretary's particulars changed
6 Sept 2005
Return made up to 15/08/05; full list of members · Director's particulars changed
11 Apr 2005
Director resigned
There are no publications matching your search.

Mentions

2 Nov 2026 in Ler
Direct parent
2 Nov 2026 in Ler
Ultimate parent
There are no publications matching your search.

The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.

Printing is only available to North Data premium service subscribers.